Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
The Political Turf Battle Over the Future of Your Prime Rib
The White House must decide whether the Food and Drug Administration or Agriculture Department will oversee the food-company scientists tweaking genes to make animals heat
AI-Generated Data Could Be a Boon for Healthcare—If Only It Seemed More Real
What to Read Next Source link
CVS Reports Stronger Demand
The healthcare company said a 10.3% increase in its second-quarter sales was driven by growth in its health benefits business. Source link
Employers Cut Off Access to Weight-Loss Drugs for Workers
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
Family of Henrietta Lacks, Whose Unique Cells Changed Science, Settles With Thermo Fisher
What to Read Next Source link
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
CVS to Shed 5,000 Jobs in Cost-Cutting Push
The healthcare giant wants to trim corporate roles and spending on travel and its use of consultants. Source link
Apple, Amazon, Starbucks to Report in Packed Earnings Week
Earnings reports also from Uber Technologies, Pfizer and Kraft Heinz are expected to shed light on how consumer spending is holding up amid rising interest
Biogen to Buy Reata in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link